BON Announces Advancement in Sulforaphane, Paving the Way for Rapid Development of Broccoli Extract Products
Portfolio Pulse from Benzinga Newsdesk
Bon Natural Life Limited (NASDAQ:BON) announced a breakthrough in converting glucoraphanin into sulforaphane for broccoli extract products. The new compound system enhances transformation rate, bioavailability, and reduces costs, leading to rapid market expansion and longer shelf life. BON plans to launch Broclife® health supplements targeting sleep, digestive, and immune health. The CEO anticipates this innovation to drive substantial growth and shareholder value, with a market potential of tens of millions of dollars over three years.
November 30, 2023 | 2:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BON's technological advancement in broccoli extract production could lead to cost reductions, market expansion, and new product launches under the Broclife® brand, potentially increasing revenues and shareholder value.
The announcement of a technological breakthrough typically generates positive investor sentiment, especially when it promises to reduce production costs, enhance product effectiveness, and tap into new markets. BON's advancement in broccoli extract production and the planned launch of Broclife® products are likely to be viewed favorably by investors, potentially leading to a short-term increase in BON's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100